Geng Peng-Fei, Wang Cong-Cong, Li Zhong-Hua, Hu Xiao-Ning, Zhao Tao-Qian, Fu Dong-Jun, Zhao Bing, Yu Bin, Liu Hong-Min
Key Laboratory of Advanced Drug Preparation Technologies (Zhengzhou University), Ministry of Education, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China; Key Laboratory of Henan Province for Drug Quality and Evaluation, PR China.
Key Laboratory of Advanced Drug Preparation Technologies (Zhengzhou University), Ministry of Education, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China; Key Laboratory of Henan Province for Drug Quality and Evaluation, PR China.
Eur J Med Chem. 2018 Jan 1;143:1959-1967. doi: 10.1016/j.ejmech.2017.11.009. Epub 2017 Nov 5.
Pteridines are an important class of fused heterocycles found in natural products and drug molecules, and have shown diverse biological activities. A focused library of 5,8-dihydropteridine-6,7-dione derivatives were designed and evaluated for their antiproliferative activity against MGC-803, SGC-7901, A549 and PC-3 cancer cell lines. The SARs studies highlighted the importance of the piperazine substituted 5,8-dihydropteridine-6,7-dione frameworks for the activity and revealed essential structural elements. Among these compounds, compound 5n displayed the most potent and broad-spectrum antiproliferative inhibition against the tested cell lines and was sensitive to MGC-803 cell line, slightly more potent than 5-FU. Preliminary mechanistic studies showed that compound 5n could inhibit the colony formation and migration of MGC-803 cells. Besides, flow cytometry analysis showed that compound 5n concentration-dependently induced apoptosis of MGC-803 cells. Our studies suggest that the piperazine substituted 5,8-dihydropteridine-6,7-dione frameworks may be regarded as new chemotypes for designing effective antitumor agents targeting gastric cancer cells.
蝶啶是一类重要的稠合杂环化合物,存在于天然产物和药物分子中,并已显示出多种生物活性。设计并评估了一个聚焦的5,8-二氢蝶啶-6,7-二酮衍生物库,以研究其对MGC-803、SGC-7901、A549和PC-3癌细胞系的抗增殖活性。构效关系研究突出了哌嗪取代的5,8-二氢蝶啶-6,7-二酮骨架对活性的重要性,并揭示了关键结构要素。在这些化合物中,化合物5n对测试细胞系表现出最有效和广谱的抗增殖抑制作用,对MGC-803细胞系敏感,比5-氟尿嘧啶稍强。初步机制研究表明,化合物5n可抑制MGC-803细胞的集落形成和迁移能力。此外,流式细胞术分析表明,化合物5n可浓度依赖性地诱导MGC-803细胞凋亡。我们的研究表明,哌嗪取代的5,8-二氢蝶啶-6,7-二酮骨架可被视为设计靶向胃癌细胞的有效抗肿瘤药物的新化学类型。